These are very reasonable and prudent end of year bonus for a management team that just got FDA approval of a new cancer drug. Give me a break if you're worried about these. Small compared to peers or other verticals and in my view even though I am #$%$ off at the sell off these are well deserved and happy holidays to the team.
Catch the Motley Fool articles on stocks to watch in 2013 I couldn't agree more, still adding here under $4.50
Now let's see if Morrissey buys $64,500.00(his bonus money) worth of EXEL shares in the open market. Hell, Gisela can buy $75,000.00 worth. LOL
Maybe they should have all opted to take shares instead of cash. Now that would have been the right way to handle it, but wait they already get plenty of free options anyway. However, it would be a vote of confidence if the major executives of the company used their own actual cash to buy in the "open" market, with the rest of us 98%ers.LOL